read more

first_img News | Neuro Imaging | August 16, 2019 ADHD Medication May Affect Brain Development in Children A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect development of the brain’s… read more News | Magnetic Resonance Imaging (MRI) | August 01, 2019 | Jeff Zagoudis, Associate Editor FDA Issues Draft Guidance on Medical Device Safety in MRI Environment The U.S. Food and Drug Administration (FDA) issued a new draft guidance titled Testing and Labeling Medical Devices for… read more News | Focused Ultrasound Therapy | July 10, 2019 Insightec’s Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s… read more News | Neuro Imaging | July 05, 2019 Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American… read more News | Image Guided Radiation Therapy (IGRT) | July 16, 2019 AAPM 2019 Features More Than 40 Presentations on ViewRay’s MRIdian MRI-guided Radiotherapy ViewRay Inc. announced that the company’s MRIdian System is the focus of more than 40 abstracts selected by the… read more April 21, 2014 — Providence Saint Joseph Medical Center in Burbank, Calif., is the first hospital in the nation to conduct a magnetic resonance imaging (MRI) scan of a patient implanted with a new MRI-compatible pacemaker — a breakthrough because metal implants often exclude patients from this imaging because of the strong magnetic force.Cardiothoracic surgeon Raymond Schaerf, M.D., implanted the Accent MRI Pacemaker and Tendril MRI Lead in Karolyi Fenyvesi, 82, of Burbank, who successfully underwent magnetic resonance imaging.Led by Schaerf, Providence Saint Joseph was part a global clinical study to help determine if a patient can safely and effectively undergo a full-body, high-resolution MRI scan with the Accent MRI system.Many patients with pacemakers and defibrillators need MRI studies to help with their care and diagnoses, said Schaerf, a leader in the study of MRI use on patients with implanted devices including pacemakers and defibrillators. The Accent pacemaker was designed to be compatible with MRI, often the preferred diagnostic tool for some medical conditions such as cancer, stroke, spine and neurological disorders.”We have been privileged to have done more than 400 MRI studies through an FDA-approved study over the last six years, but are restricted in what studies can be performed,” Schaerf said. “With this device and system, we have made a great leap forward, and in this patient actually did an MRI of the heart, with no problems and no artifacts on the scan caused by metal.”Cardiac pacemakers are used to help treat abnormal heart rhythms. In this clinical study, a pacemaker is implanted to help treat a patient with bradycardia, a dangerously slow heart rate. A pacemaker helps monitor the heart and provides electrical stimulation when the heart beat is too slow.The investigational Accent MRI pacemaker and Tendril MRI lead can be used for full-body scans without any anatomical restrictions because of technology designed to protect a patient from the risks associated with an MRI environment.More than 60 million MRI scans are performed each year around the globe. Pacemaker patients typically are discouraged from receiving MRI scans because their pacing system may be affected during the scan.The Accent MRI Pacemaker and Tendril MRI lead, developed by St. Jude Medical, are available in Europe and Japan. In March 2012, St. Jude Medical received conditional investigational device exemption approval from the U.S. Food and Drug Administration (FDA) to start enrollment in this clinical study.For more information: www.california.providence.org. FacebookTwitterLinkedInPrint分享 Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco News | Magnetic Resonance Imaging (MRI) | August 06, 2019 Canon Medical Introduces Encore Orian MR Upgrade Program Canon Medical Systems USA Inc. is helping to provide low-cost patient care solutions for its customers with the launch… read more Feature | Contrast Media | July 18, 2019 | By Greg Freiherr How To Manage Risk in the MR Suite Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n read more Technology | Interventional Radiology | August 16, 2019 Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to… read more News | April 21, 2014 First U.S. Patient Receives MRI Scan in Clinical Study of St. Jude MRI-Compatible Pacemaker Providence Saint Joseph Medical Center announces first scan in study Technology | Neuro Imaging | August 07, 2019 Synaptive Medical Launches Modus Plan With Automated Tractography Segmentation Synaptive Medical announced the U.S. launch and availability of Modus Plan featuring BrightMatter AutoSeg. This release… read more Images of regions of interest (colored lines) in the white matter skeleton representation. Data from left and right anterior thalamic radiation (ATR) were averaged. Image courtesy of C. Bouziane et al. Technology | Contrast Media | July 15, 2019 FDA Approves Bayer’s Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance… read more Related Contentlast_img read more